Hepatic fibrosis: are any of the serum markers useful? (Q31934986)

5 July 2017

1 reference

title

Hepatic fibrosis: are any of the serum markers useful? (English)

1 reference

5 July 2017

Oh S

1

1 reference

PubMed ID

11177689

5 July 2017

Afdhal NH

series ordinal

2

1 reference

5 July 2017

1 February 2001

1 reference

Current gastroenterology reports

5 July 2017

1 reference

5 July 2017

3

1 reference

5 July 2017

1

1 reference

5 July 2017

12-18

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-001-0035-2

5 July 2017

0 references

cites work

The catabolic fate of hyaluronic acid

1 reference

12 December 2020

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

12 December 2020

Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy

1 reference

12 December 2020

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1 reference

12 December 2020

Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin

1 reference

12 December 2020

Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan

1 reference

12 December 2020

[Procollagen III and laminin in chronic viral hepatopathies]

1 reference

12 December 2020

Serum hyaluronan as a disease marker

1 reference

12 December 2020

Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats

1 reference

12 December 2020

Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis

1 reference

12 December 2020

Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease

1 reference

12 December 2020

Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease

1 reference

12 December 2020

Collagens of normal and cirrhotic human liver

1 reference

12 December 2020

Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?

1 reference

12 December 2020

Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN

1 reference

12 December 2020

Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C

1 reference

12 December 2020

Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage

1 reference

12 December 2020

Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition

1 reference

12 December 2020

Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease

1 reference

12 December 2020

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

1 reference

12 December 2020

Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon

1 reference

12 December 2020

Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats

1 reference

12 December 2020

Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers

1 reference

12 December 2020

Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease

1 reference

12 December 2020

Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value

1 reference

12 December 2020

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

1 reference

12 December 2020

Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C

1 reference

12 December 2020

Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate.

1 reference

12 December 2020

Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis

1 reference

12 December 2020

Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers

1 reference

12 December 2020

Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response

1 reference

12 December 2020

Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon

1 reference

12 December 2020

Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system

1 reference

12 December 2020

Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis

1 reference

12 December 2020

Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin

1 reference

12 December 2020

Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis

1 reference

12 December 2020

Clinical significance of serum hyaluronan in patients with chronic viral liver disease

1 reference

12 December 2020

Serum YKL-40 is increased in patients with hepatic fibrosis

1 reference

12 December 2020

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

12 December 2020

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

1 reference

12 December 2020

Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease

1 reference

12 December 2020

Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests

1 reference

12 December 2020

Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?

1 reference

12 December 2020

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis

1 reference

12 December 2020

Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity

1 reference

12 December 2020

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology

1 reference

12 December 2020

Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake

1 reference

12 December 2020

Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis

1 reference

12 December 2020

Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables

1 reference

12 December 2020

Increased transforming growth factor-beta 1 gene expression in human liver disease

1 reference

12 December 2020

10.1007/S11894-001-0035-2

Identifiers

DOI

1 reference

PubMed ID

11177689

Dimensions Publication ID

5 July 2017

0 references

1 reference

PubMed ID

11177689